UnitedHealth Group Incorporated (NYSE:UNH) is Hyperion Capital Advisors LP’s 5th Largest Position

Hyperion Capital Advisors LP lowered its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.5% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 25,230 shares of the healthcare conglomerate’s stock after selling 397 shares during the quarter. UnitedHealth Group accounts for approximately 6.6% of Hyperion Capital Advisors LP’s investment portfolio, making the stock its 5th biggest holding. Hyperion Capital Advisors LP’s holdings in UnitedHealth Group were worth $12,763,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the business. NewSquare Capital LLC bought a new position in UnitedHealth Group during the fourth quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new position in shares of UnitedHealth Group in the fourth quarter worth $26,000. Hurley Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $28,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group in the 4th quarter worth about $30,000. Finally, Aster Capital Management DIFC Ltd purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth about $30,000. 87.86% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

UNH has been the topic of several recent analyst reports. Robert W. Baird lowered their target price on shares of UnitedHealth Group from $640.00 to $510.00 and set an “outperform” rating on the stock in a research note on Tuesday, April 29th. JPMorgan Chase & Co. dropped their price objective on UnitedHealth Group from $652.00 to $525.00 and set an “overweight” rating for the company in a research note on Thursday, April 24th. Morgan Stanley lowered their price target on UnitedHealth Group from $664.00 to $563.00 and set an “overweight” rating on the stock in a report on Tuesday, April 22nd. KeyCorp lowered their target price on shares of UnitedHealth Group from $650.00 to $575.00 and set an “overweight” rating on the stock in a research note on Monday, April 21st. Finally, Royal Bank of Canada lowered their price objective on shares of UnitedHealth Group from $655.00 to $525.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 23rd. Four research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $596.86.

UnitedHealth Group Trading Down 1.3 %

UnitedHealth Group stock opened at $380.72 on Friday. UnitedHealth Group Incorporated has a 12 month low of $378.54 and a 12 month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The business’s fifty day simple moving average is $488.01 and its two-hundred day simple moving average is $522.31. The company has a market capitalization of $346.54 billion, a price-to-earnings ratio of 24.56, a price-to-earnings-growth ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. During the same period last year, the firm posted $6.91 earnings per share. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 2.21%. UnitedHealth Group’s payout ratio is 35.18%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.